MicroRNAs and periodontal disease: a qualitative systematic review of human studies

Pablo Micó-Martínez1, Pedro J Almiñana-Pastor2, Francisco Alpiste-Illueca2

  • 1Department of Stomatology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain. paumico90@gmail.com.

Abstract

Insights

MicroRNAs (miRNAs) show promise as biomarkers for periodontal disease. Research indicates elevated miR-146a levels in periodontitis patients, suggesting potential for early diagnosis and monitoring.

Area of Science:

  • Biomolecular mechanisms
  • Genetics and Epigenetics
  • Oral Health Research

Background:

  • MicroRNAs (miRNAs) are key epigenetic regulators of gene expression.
  • miRNAs are emerging as critical biomarkers for various diseases, including cancer.
  • Periodontal disease involves complex inflammatory processes influenced by gene regulation.

Purpose of the Study:

  • To systematically review the association between miRNAs and human periodontal disease.
  • To assess the diagnostic and prognostic potential of miRNAs in periodontitis.
  • To consolidate current research on miRNA biomarkers in periodontology.

Main Methods:

  • Systematic review adhering to PRISMA guidelines.
  • Comprehensive literature search across multiple major scientific databases (MEDLINE, Scopus, Embase, etc.).
  • Analysis of miRNA expression levels in human studies comparing periodontitis patients and healthy controls.

Main Results:

  • 23 studies were included from 1,299 initial references.
  • Heterogeneous study designs precluded meta-analysis.
  • miR-146a was the most studied miRNA, with most studies showing higher expression in periodontitis.
  • Target genes related to periodontal inflammation were identified for differentially expressed miRNAs.

Conclusions:

  • Current findings on miRNAs in periodontal disease are promising.
  • Further diagnostic validation is required to establish miRNAs as clinical biomarkers.
  • miRNAs may aid in the early detection and monitoring of periodontitis.